Moneycontrol
Moneycontrol PRO
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
MARKETS

Bafna Pharmaceuticals Ltd.

BSE: 532989 | NSE: BAFNAPH |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE878I01022 | SECTOR: Pharmaceuticals & Drugs

| BSE 145.00 12.40 (9.35%) | |

BSE Live

Apr 10, 16:01
145.00 12.40 (9.35%)
Volume
AVERAGE VOLUME
5-Day
279
10-Day
675
30-Day
417
306

  • Prev. Close

    132.60

  • Open Price

    145.60

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Apr 10, 15:49
140.91 4.78 (3.51%)
Volume
AVERAGE VOLUME
5-Day
3,159
10-Day
4,473
30-Day
4,892
23,538

  • Prev. Close

    136.13

  • Open Price

    147.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Get full access to SWOT Analysis of stock with Moneycontrol Pro.

Strengths (8)
  • Company with Low Debt
  • Increasing Revenue every quarter for the past 2 quarters

Get full access to SWOT Analysis of stock with Moneycontrol Pro.

Weaknesses (7)
  • Degrowth in Revenue and Profit
  • Inefficient use of shareholder funds - ROE declining

Get full access to SWOT Analysis of stock with Moneycontrol Pro.

Opportunities (1)
  • Companies with Price to Earnings (PE) less than average 3 Year PE, 5 Year PE and 10 Year PE

Get full access to SWOT Analysis of stock with Moneycontrol Pro.

Threats (1)
  • Negative growth with promoters decreasing shareholding
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347